← Eichor
Study identifier: NCT07086638 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer

Condition: Radiation Dermatitis  ·  Sponsor: West China Hospital

PhaseNA
Planned participants5
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Severe radiation dermatitis remains a challenging complication in head and neck cancer with limited treatment options; this study aims to evaluate a novel Prussian blue-based nanozyme combined with near-infrared thermotherapy to promote effective healing of Grade III lesions.

This description comes directly from the study's public registry record.

Talk to the study team

Xingchen Peng  ·  +86 18980606753  ·  pxx2014@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sichuan University West China HospitalChengdu, Sichuan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07086638